Krasznai et al. [12] also demonstrated that the combined treatment with UIC2 antibody and Pgp modulators effectively blocked the function of Pgp in ovarian carcinoma cells in vitro and the effect could be followed by using tumor diagnostic tracers, 99mTc-MIBI and 18FDG. The gene discussed is PGP; the disease is ovarian carcinoma.